Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Diabetic Nephropathy Trial (CDNT)
NCT02442921Phase 2Unknown
- Sponsor
- Sheba Medical Center
- Start
- Feb 2016
- Primary completion
- Apr 2019
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in diabetic nephropathy (DN), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
colchicine
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02442921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02442921.